Erythrocyte zinc content in critically ill patients

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 9, 2005, Pages 930-933

  Cutinha, Darren ^a   Vaja, Sashi ^a   Treacher, David ^a   Swaminathan, R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Critical illness; Erythrocyte zinc; Hypothyroidism; Non thyroidal illness; Tissue markers

Indexed keywords

THYROID HORMONE; ZINC;

ARTICLE; CELL AGING; CELL SEPARATION; CENTRIFUGATION; CONTROLLED STUDY; CRITICAL ILLNESS; DIAGNOSTIC VALUE; ERYTHROCYTE LEVEL; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HYPERTHYROIDISM; HYPOTHYROIDISM; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL PATIENT; THYROID FUNCTION TEST; THYROID HORMONE BLOOD LEVEL;

ACUTE DISEASE; CASE-CONTROL STUDIES; CREATINE; CRITICAL ILLNESS; ERYTHROCYTES; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; THYROID GLAND; THYROID HORMONES; ZINC;

EID: 26844523179     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2005.159     Document Type: Article

References (28)

1. Chopra IJ. Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab 1995;82:329-34.
2. LoPresti JS, Nicoloff JT. Thyroid response to critical illness. Contemporary endocrinology. In: Ober KP, editor. Endocrinology of critical disease. Totowa, New Jersey: Humana Press, 1997:155-73.
3. Maldonado LS, Murata GH, Hershman JM, Braunstein GD. Do thyroid function tests independently predict survival in the critically ill? Thyroid 1992;2:119-23.
4. 3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 2003;107:708-11.
5. Mak YT, Chan EL, Chan A, Woo J, Swaminathan R. Free triiodothyronine in serum of acutely ill general medical patients: a prognostic indicator? Clin Chem 1992;38: 414-5.
6. Ray DC, Drummond GB, Wilkinson E, Beckett GJ. Admission tyrotrophin concentrations do not predict outcome in critical illness. Anaesthesia 1995;50:1022-5.
7. Ekins R. Measurement of free hormones in blood. Endocr Rev 1990;11:5-46.
8. De Groot LJ. Dangerous dogmas in medicine: the nonthyroid illness syndrome. J Clin Endocrinol Metab 1999; 84:151-64.
9. Melmed S, Geola FL, Reed AW, Packary AE, Park J, Hershaman JM. A comparison of methods for assessing thyroid function in non thyroidal illness. J Clin Endocrinol Metab 1982;54:300-6.
10. Arem R, Wiener GJ, Kaplan SG, Kim HS, Reichlim S, Kaplan MM. Reduced tissue thyroid hormone levels in fatal illness. Metabolism 1993;42:1102-8.
11. Brent GA, Hershman JM, Reed AW, Sasta A, Lieberman J. Serum angiotensin converting enzyme in severe nonthyroidal illness associated with low serum thyroxine concentration. Ann Intern Med 1986;100:680-3.
12. Seppel T, Becker A, Lippert F, Schlaghecke F. Serum sex hormone binding globulin and osteocalcin in systemic non-thyroidal illness associated with low thyroid hormone concentrations. J Clin Endocrinol Metab 1996;8: 1663-5.
13. Yoshida K, Kiso Y, Watanabe T, Kaisi K, Kaisi N, Fukazawa H, et al. Clinical utility of red blood cell carbonic anhydrase I and zinc concentrations in patients with thyroid diseases. Metabolism 1991;40:1048-51.
14. Swaminathan R, Segall WH, Chapman C, Morgan DB. Red blood cell composition in thyroid disease. Lancet 1976;2:1382-5.
15. Lao TT, Chin RK, Swaminathan R, Panesar NS, Cockram CS. Erythrocyte zinc in the differential diagnosis of hyperthyroidism in pregnancy: a preliminary report. Br Med J 1987;294:1064-5.
16. Chan AY, Mak YT, Shek CC, Swaminathan R. Changes in erythrocyte zinc in a case of transient thyrotoxicosis. Ann Clin Biochem 1991;28:524-5.
17. Murphy JR. Influence of temperature and method of centrifugation on the separation of erythrocytes. J Lab Clin Med 1993;82:334-41.
18. Arumanayagam M, MacDonald D, Cockram CS, Swaminathan R. The effect of hyperthyroidism on in vivo ageing of erythrocyte ouabain binding sites and intracellular sodium and potassium. J Clin Endocrinol Metab 1990; 71:260-3.
19. Li PK, Lee JT, Li CS, Deshpande G. Improved method for determining erythrocyte creatine by the diacetyl-alphanaphthol reaction: elimination of endogenous glutathione interference. Clin Chem 1982;28:92-6.
20. Hambridge M. Biomarkers of trace mineral intake and status. Am J Clin Nutr 2003;133:9485-555.
21. Mafra D, Cozzolino MF. Erythrocyte zinc and carbonic anhydrase levels in nondialyzed chronic kidney disease patients. Clin Biochem 2004;37:67-71.
22. Gorodetsky R, Fuks Z, Sulkes A, Ginsburg H, Weshler Z. Correlation of erythrocyte and plasma levels of zinc, copper, and iron with evidence of metastatic spread in cancer patients. Cancer 1985;15:779-87.
23. 2+ in essential hypertension. Acta Med Scand 1979;205: 647-9.
24. Bergomi M, Rovesti S, Vinceti M, Vivoli R, Caselgrandi E, Vivoli G. Zinc and copper status and blood pressure. J Trace Elem Med Biol 1997;11:166-9.
25. Hori H, Yosida K, Fukazawatl H, Kiso Y, Sayama N, Mori A, et al. Effects of thyroid hormones on carbonic anhydrase I gene expression in human erythroid cells. Thyroid 1998;8:525-31.
26. Klein I, Ojamaa, K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501-9.
27. Klemperer JD, Klein I, Gomez LL, Hehma RE, Ojama K, Thomas JS, et al. Thyroid hormone treatment after coronary artery bypass surgery. N Engl J Med 1995;333: 1522-7.
28. Beltendorf M, Schmidt KG, Grulich-Henn J, Ulme HE, Heintich UE. Triiodothyronine treatment in children after cardiac surgery: a double blind randomised, placebo-controlled study. Lancet 2000;365:529-34.